Home | Cancers | Lung Cancer

Lung Cancer

Study identifies novel genomic changes in the most common type of lung cancer

TCGA finds mutations in a key cancer-causing pathway, expanding targets for existing drugs ...

Lung cancer study hints at new treatments

By Julia Evangelou Strait - Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that ...

New Program to Detect Early Lung Cancer in Current and Former Smokers

CT scans lower lung cancer deaths, according to NIH study ... Full story

Surgical biopsy proves safe for selected late-stage lung cancer patients

Findings should promote use of targeted treatments ... Full story

Lung cancer study focuses on a more targeted treatment option

Houston, TX - A new study offered at Houston Methodist Hospital will compare an emerging immunotherapy drug to an existing chemotherapy drug and look at the effects both drugs have on the development of non-small cell lung cancer, a type of cancer which makes up about 85 percent of lung cancer cases. Lung cancer is the second most common malignancy in the United States. ... Full story

A New Tool to Confront Lung Cancer

Only 15% of patients with squamous cell lung cancer – the second most common lung cancer – survive five years past diagnosis. Little is understood about how the deadly disease arises, preventing development of targeted therapies that could serve as a second line of defense once standard chemotherapy regimens fail. ... Full story

UCLA scientists identify link between stem cell regulation and the development of lung cancer

Shaun Mason - Electron microscopy of normal airway epithelial cells repairing after injury (left) and delaying repair (right), when the reactive oxygen species are unable to undergo flux to signal the repair process. ... Full story

Study investigates online information available to lung cancer patients

Researchers from The University of Manchester have begun a study to look at the online information available to lung cancer patients in an era of diagnosis by google. ... Full story

Groundbreaking lung cancer trial launched

UC Davis expert David Gandara a key architect of national effort ... Full story

New model estimates smoking's legal attribution to lung cancer cases

A newly developed model estimates smoking's attribution to lung cancer and finds that more than 90 percent of Quebec lung cancer cases can be legally attributed to smoking, according to a new study in the American Journal of Public Health published by Jack Siemiatycki of the University of Montreal's Institute for Public Health Research. Legal attribution incorporates the notion of “more likely than not” or equivalently that the probability of causation due to smoking was greater than 0.50. ... Full story

1 2 3 4 5 6 7 8 next total: 76 | displaying: 1 - 10